The end of AIDS is within our reach. But as the authors of a new special supplement in the August 2012 issue of Journal of Acquired Immune Deficiencies (JAIDS) point out, new financial investments and renewed commitments from countries around the world will be critical to fully implement proven treatment and prevention tools already at hand and to continue essential scientific research.
"Only then will an AIDS-free generation be possible," write the supplement's editors -- Richard Marlink, Wafaa El-Sadr, Mariangela Simao and Elly Katabira in their introduction. "Are we willing to pay the price to turn the dream into a reality?" they ask.
Titled "Engaging to End the Epidemic: Seven Essential Steps Toward an AIDS-Free Generation," the supplement identifies the seven key areas where money and political will must be focused to end AIDS. These include:
Â
1. The promise and challenges of using antiretroviral drugs (ARVs) to prevent HIV transmission
Â
2. New AIDS treatments, improving the ARV pipeline to treat those infected, and working toward a cure
Â
3. Enhancing the role of government leaders, the private sector, and non-governmental organizations (NGOS) in driving local and national responses to the epidemic
Â
4. Narrowing health disparities in preventing and treating AIDS caused by economic disempowerment, discrimination, and stigma
5. Preventing AIDS transmission from mothers to babies in low- and middle-income countries where access to prevention services are most limited, but where new drug interventions show AIDS could be virtually eliminated in infants and children
6. Funding the pursuit for AIDS vaccines, which are necessary to actually eliminate the disease
Â
7. Maximizing and growing current investments in the global AIDS response, rather than decreasing funding. In addition to its humanitarian impact, money spent going forward is a good global and local investment because improving and sustaining people's health enables them to be productive members of society contributing to the growth of their nations' economies.
Â
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.